Laurienne Edgar
Abingdon
Summary
Dynamic professional with expertise in strategic planning, communication skills, and problem-solving. Demonstrates strong leadership and team building capabilities, driving successful outcomes in collaborative environments. Committed to leveraging these skills to achieve organisational goals and foster growth.
Energetic employee well-versed in strong communication and organisation skills. Seeks solutions to problems and applies extensive analytical knowledge to findings. Adept at multi-tasking, leading group discussions and managing projects.
Overview
14
14
years of professional experience
Work history
Senior Clinical Medical Advisor, Obesity & Related Conditions
Amgen
UK, Spain & Italy
05.2025 - 02.2026
- Spearhead obesity medical activities and oversee all phase 3 clinical trials within obesity and related conditions across UK, Spain, and Italy for monthly incretin therapy.
- Drive recruitment and retention strategies to enhance participant engagement and ensure alignment with global objectives.
- Directed comprehensive medical leadership for obesity across multiple markets, ensuring operational coherence in clinical development, marketing, market access, and financial strategies.
- Facilitated creation and distribution of clinical trial retention handbook.
Assisted in strategy development and compliance approval processes by collaborating with various departments.
Supported global training initiatives for over 500 stakeholders, enhancing knowledge and resource utilisation.
Senior Brand Manager, Diabetes & Obesity Marketing
Eli Lilly
UK & Ireland
05.2024 - 05.2025
- Spearheaded brand development for Mounjaro, focusing on type 2 diabetes (T2D) and weight management strategies.
Directed creation and implementation of insight-driven tactics to drive brand success.
Led marketing strategy development for Ireland Mounjaro launch, ensuring field force readiness for optimal impact. - Most successful incretin UK launch; Mounjaro leads share of market in both NHS and private sectors with $408 million revenue in first 9 months from ~ 3.3 million pack sales.
- Developed Rise Together peer-to-peer programme to elevate awareness and understanding of Mounjaro by leveraging OCE segmentation for customised educational journeys aligned with local environment needs.
- Increased customer engagement by generating strategic methods to expand reach and promote 6 new meeting titles.
Enhanced participation through implementation of various invite formats.
Delivered a dynamic registration platform and programme leave piece, resulting in improved attendee experience. - Partnered with certifiers and maximised cross-functional collaboration to deliver in a compliant and effective way, and meeting MHRA pre-vetting requirements
- Enabled rapid success, with 542 attending 36 meetings within the 1st month.
- Drive successful Ireland launch by strategically identifying prioritised tactics and optimising training materials to enhance team effectiveness.
- Developed and localised global and regional combined 'one brand' strategy through creation of strategy playbook and alignment of 2025 tactics to an obesity-first narrative, facilitating further Mounjaro success.
- Monitored performance metrics to evaluate success of branding initiatives.
Senior Advisor, Diabetes & Obesity Medical Affairs
Eli Lilly
UK & Ireland
06.2023 - 06.2024
- Lead on developing medical education materials, with focus on addressing clinical care gap (CCG) and product knowledge gap (PKG) across diabetes and obesity, as well as being medical lead for the UK’s largest diabetes medical education meeting: UK Clinical Diabetologist Forum (UKCDF).
- Led on producing a pen demo for HCP and patient use accelerating the process to meet a key need, from concept to completion of filming in 24 hours.
- Partnered in developing brand tactics, thought leader engagement strategy and medical education omnichannel engagement tactics, to ensure these are innovative and data-driven.
- Awarded 2 awards at the September diabetes launch sales training meetings for working cross functionally, demonstrating clear understanding of the Mounjaro brand strategy and translating it into interactions and planning.
- Innovated the way MSL decks and medical slides are created and structured an interactive master deck that allows for intuitive reactive field medical use, aligned communication and streamlined sign off for future use by the cross-functional team.
Senior Regional Medical Advisor (RMA)
Novo Nordisk
UK
10.2022 - 05.2023
- Provided high level medical and scientific support, education and training to HCPs across Birmingham, Leicester and the Black Country as well as be a medical lead for the commercial field team.
- Member of working group who developed medical strategy and reactive material generation for once weekly insulin icodec, leading on field medical training strategy & implementation.
- Founder and author of diabetes field medical team obesity training strategy on Wegovy.
- Active member of the injectables’ Brand Team to support communicating the field’s medical insights, in particular those pertinent to the GLP-1RA cardiorenal strategy.
- Provided scientific and creative input to cardiology market research survey which was pivotal to 2 new campaigns for the injectable GLP-1RA commercial team and thought leader mapping.
Senior Global Scientific Recruitment & Retention (SRR) Manager, Global Medical Affairs
Novo Nordisk HQ
Copenhagen, Denmark
08.2021 - 09.2022
- Senior project manager responsible for leading a cross functional team and a Global Expert Panel (GEP), compiled of Global thought leaders, to develop and execute trial strategies to ensure successful recruitment and retention of participants in 3 of Novo Nordisk’s large global outcome trials: SELECT (semaglutide in obesity CVOT), FOCUS (semaglutide in diabetic retinopathy), evoke (semaglutide in Alzheimer’s Disease) and REDEFINE 3 (cagrimesa CVOT).
- Identifying challenges, working closely with key stakeholders up to senior management level, including Clinical Operations, Medical Affairs and Medical & Science, and leading diverse expert KOLs engagements to develop and implement scientific communication, recruitment and retention tools and educational materials for participants and site staff in these trials.
- Promoted to Senior role within 5 months.
Regional Medical Advisor (RMA)
Novo Nordisk
UK
01.2019 - 07.2021
- Responsible for communicating complicated scientific data in a simple, balanced and impactful way to support national and local commercial needs and in response to medical requests.
- Strong interpersonal skills drive an ability to build and maintain relationships internally and with leading experts in diabetes, cardiology, nephrology, obesity and primary care.
- Winner of the PharmaTimes national award for “Best New Medical Science Liaison”, as well as being named as a Novo Nordisk European top performer and won the UK gold award for top performing diabetes RMA.
Researcher
Boehringer Ingelheim
Biberach an der Riss, Germany
06.2012 - 07.2013
- Selected for a 1-year industry research placement.
- Drove forward an individual research project developing and characterising novel therapeutic antibodies against immune targets involved in severe asthma.
Education
DPhil - Cardiovascular Science
University of Oxford
09.2014 - 12 2018
BSc - Pharmacology with Industrial Experience
University of Manchester
09.2010 - 7 2014
Skills
- Strategic planning
- Communication skills
- Problem-solving
- Leadership
- Team building
Websites
Hobbies and Interests
In my spare time I am a keen runner having completed 8 full marathons and currently training for 2 more this year. I love rowing and represented my Oxford college’s woman’s first boat for all 4 years, winning two rowing blades and 1 coxing blade during their bi-annual bumps races. And for my sins, I’m attempting to learn and play golf.
Languages
English
Native
Spanish
Beginner
French
Beginner
German
Beginner
Accomplishments
Evans M, Evans W, Godbeer F, Edgar L, Spaepen E, Davies AL. Analysis of Tirzepatide Acquisition Costs and Weight Reduction Outcomes in the United Kingdom: Insights from the SURMOUNT-1 Study. Adv Ther. 2025 Jun;42(6):2821-2832. doi: 10.1007/s12325-025-03194-8. Epub 2025 Apr 18. PMID: 40251452; PMCID: PMC12085389.
Edgar L, Akbar N, Braithwaite AT, Krausgruber T, Gallart-Ayala H, Bailey J, Corbin AL, Khoyratty TE, Chai JT, Alkhalil M, Rendeiro AF, Ziberna K, Arya R, Cahill TJ, Bock C, Laurencikiene J, Crabtree MJ, Lemieux ME, Riksen NP, Netea MG, Wheelock CE, Channon KM, Rydén M, Udalova IA, Carnicer R, Choudhury RP. Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis. Circulation. 2021 Sep 21;144(12):961-982. doi: 10.1161/CIRCULATIONAHA.120.046464. Epub 2021 Jul 13. PMID: 34255973; PMCID: PMC8448412.
Choudhury RP, Edgar L, Rydén M, Fisher EA. Diabetes and Metabolic Drivers of Trained Immunity: New Therapeutic Targets Beyond Glucose. Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1284-1290. doi: 10.1161/ATVBAHA.120.314211. Epub 2021 Mar 4. PMID: 33657881; PMCID: PMC10069665.
British Society of Cardiovascular Society Young Investigator Award Winner - 2018
PharmaTimes National Awards - winner 2019; judge since 2025 until present
Affiliations
- Running
- Golf
- Dance teacher
Timeline
Senior Clinical Medical Advisor, Obesity & Related Conditions
Amgen
05.2025 - 02.2026
Senior Brand Manager, Diabetes & Obesity Marketing
Eli Lilly
05.2024 - 05.2025
Senior Advisor, Diabetes & Obesity Medical Affairs
Eli Lilly
06.2023 - 06.2024
Senior Regional Medical Advisor (RMA)
Novo Nordisk
10.2022 - 05.2023
Senior Global Scientific Recruitment & Retention (SRR) Manager, Global Medical Affairs
Novo Nordisk HQ
08.2021 - 09.2022
Regional Medical Advisor (RMA)
Novo Nordisk
01.2019 - 07.2021
DPhil - Cardiovascular Science
University of Oxford
09.2014 - 12 2018
Researcher
Boehringer Ingelheim
06.2012 - 07.2013
BSc - Pharmacology with Industrial Experience
University of Manchester
09.2010 - 7 2014